Ceo-Two (potassium bitartrate / sodium bicarbonate) Disease Interactions
There is 1 disease interaction with Ceo-Two (potassium bitartrate / sodium bicarbonate):
Alkalinizing agents (Includes Ceo-Two) ↔ sodium/water balance
Severe Potential Hazard, High plausibility. Applies to: Congestive Heart Failure, Fluid Retention, Hypernatremia
Alkalinizing agents containing sodium can induce sodium and water retention and result in hypernatremia, hypokalemia, hyperosmolality, edema and aggravation of congestive heart failure. Therapy with sodium- containing alkalinizing agents should not be used in patients with hypernatremia or fluid retention. Clinical monitoring of acid/base balance and electrolytes prior to, during, a following completion of therapy with alkalinizing agents is recommended.
- "Product Information. Sodium Bicarbonate (sodium bicarbonate)." Astra USA, Westborough, MA.
- "Product Information. Sodium Lactate (sodium lactate)." Abbott Pharmaceutical, Abbott Park, IL.
Ceo-Two (potassium bitartrate / sodium bicarbonate) drug interactions
There are 582 drug interactions with Ceo-Two (potassium bitartrate / sodium bicarbonate)
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.